These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1148797)

  • 1. Letter: Prolactin, bromocriptine, and haemostasis.
    Karmali RA; Horrobin DF
    Br Med J; 1975 Aug; 3(5978):307. PubMed ID: 1148797
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Renal interactions of prolactin and bromocriptine.
    Mahajan KK; Manku MS; Davidson H; James MF; Robinson CJ; Horrobin DF
    J Endocrinol; 1976 Mar; 68(3):14P. PubMed ID: 1255072
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Effects of treatment with ovine prolactin and bromocriptine upon growth and exchangeable calcium in mice.
    Karmali RA; James MF; Horrobin DF; Robinson CJ
    J Endocrinol; 1976 Jun; 69(3):47P-48P. PubMed ID: 950541
    [No Abstract]   [Full Text] [Related]  

  • 4. Letter: Platelet and coagulation studies in patients treated with bromocriptine.
    Conard J; Samama M; Bousser MG; Bories F
    Br Med J; 1976 Aug; 2(6034):529-30. PubMed ID: 953674
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Effects of prolactin and bromocriptine on the response to Moloney sarcoma virus in mice.
    Karmali RA; Horrobin DF
    J Endocrinol; 1975 Nov; 67(2):57P-58P. PubMed ID: 1206305
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Effects of bromocriptine and prolactin on thymus growth and thymus uptake of tritiated thymidine in mice of the Swiss and Bar Harbor 129 strains.
    Horrobin DF; Karmali RA
    J Endocrinol; 1975 Nov; 67(2):58P-59P. PubMed ID: 1206306
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolactin, bromocriptine and dopaminergic neurotransmission.
    Lamberts SW; Birkenhäger JC
    Neth J Med; 1976; 19(3):113-7. PubMed ID: 6921
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulation studies in patients treated with bromocriptine.
    Harrower AD; Yap PL; Allan NC
    Br Med J; 1976 Jul; 2(6027):109-10. PubMed ID: 1276803
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of prolactin and CB154 on electrolyte concentration of amniotic fluid in the rat.
    Kühn ER; Vandoren GE
    IRCS J Med Sci; 1975 May; 3(5):246. PubMed ID: 1165170
    [No Abstract]   [Full Text] [Related]  

  • 10. Aldosterone and prolactin.
    Olgaard K; Hagen C; Madsen S; Hummer L
    Lancet; 1976 Oct; 2(7992):959. PubMed ID: 62181
    [No Abstract]   [Full Text] [Related]  

  • 11. [Letter: Inhibition of lactation by an antiprolactin substance, CB 154].
    Morin P; Engelmann P; Coustenoble G; Lebrun ; Gueris D
    Nouv Presse Med; 1975 Nov; 4(39):2811-2. PubMed ID: 1105425
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: Growth, prolactin and growth hormone in lambs treated with CB154.
    Brown WB; Driver PM; Jones R; Forbes JM
    J Endocrinol; 1976 Jun; 69(3):47P. PubMed ID: 985847
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of bromocriptine on milk secretion in the rabbit.
    Taylor JC; Peaker M
    J Endocrinol; 1975 Nov; 67(2):313-4. PubMed ID: 1239483
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolactin stimulation tests: different response patterns after bromocriptine, lisuride, and metergoline treatment of puerperal women.
    Bohnet HG; Kato K; De Moll H
    Obstet Gynecol; 1988 Jan; 71(1):53-5. PubMed ID: 3336541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prolactin and the anit-prolactin bromocriptin on the testosterone uptake and metabolism in androgen-sensitive and insensitive canine organs.
    Helmerich D; Altwein JE
    Urol Res; 1976 Nov; 4(3):101-5. PubMed ID: 1037036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two new dopamine agonists that are long acting in vivo but short acting in vitro.
    Grossman A; Yeo T; Delitala G; Hathway NR; Besser GM
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):595-9. PubMed ID: 7226572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of ergocornine, bromocriptine, D-6-methyl-8-ergolinylacetamide and D-6-propyl-8-ergolinylacetamide on the prolactin secretion in goats. Comparison of potency and duration of effect.
    Krejcí P; Rezábek K; Madej A; Stupnicki R; Ausková M; Bílek J
    Arzneimittelforschung; 1982; 32(4):365-8. PubMed ID: 6896644
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological characterization of CB 154.
    Triangle; 1975; 14(3-4):153-7. PubMed ID: 1209735
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Bromocriptine--a changing scene.
    Br Med J; 1975 Dec; 4(5998):667-8. PubMed ID: 1239326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.